Carlytene is a medicament containing the moxisylyte vasodilator properties, which relieves Raynaud's syndrome
For warnings, precautions for use and contraindications, please consult the instructions for use
Therapeutic indications: Nervous system> Memory, Circulation> Raynaud's syndrome
Family of drugs: Vasodilators
Active ingredients: Moxisylyte hydrochloride
Carlytene is a medicine containing moxisylyte with vasodilatory properties. It improves memory functions in the event of aging and relieves Raynaud's syndrome.
What it does: The moxisylyte blocks alpha 1 receptors on the blood vessels, causing them to dilate and therefore cause more blood to flow. This influx that irrigates the brain improves cognitive functions and relieves Raynaud's syndrome
1 tablet 3 times a day.
When to take it: The tablets can be taken with or without food
Duration of treatment: The duration of treatment is established under the supervision of a doctor.
Raynaud's syndrome can be both benign or hide an underlying pathology.
Raynaud's syndrome or Raynaud's disease (mild) is defined as a decrease in blood supply to the extremities (hands, feet, nose, ears ...), triggered by the cold. This phenomenon, most often completely reversible in a few minutes, results in color changes (from blue to white then to red).
Benign in its expression and its evolution, Raynaud's disease remains troublesome because it is a source of worry and sometimes pain. There is no treatment that can cure Raynaud's disease.
The main treatment for Raynaud's syndrome is based on rigorous protection of the whole body against cold and humidity. Avoidance of vasoconstrictor drugs is also necessary.
Lifestyle changes are therefore the first steps to take. They include the imperative suppression of tobacco, the protection of the whole body by warm clothes fighting against cold and humidity. Also avoid any sudden temperature change and contact with cold objects, or put your hands in the refrigerator ...
The use of vasodilator molecules intervenes as a second intention to improve the symptomatology of Raynaud's disease.
When Raynaud's syndrome appears suddenly, it is imperative to consult because it can be the symptom of a serious underlying pathology.
Box of 32 tablets
Please note, the CARLYTENE medication is not like any other product. Read the package leaflet carefully before ordering. Keep medicines out of the reach of children. If symptoms persist, seek the advice of your doctor or pharmacist. Beware of incompatibilities on your current products.
Please inform your online pharmacist of the treatments in progress in order to identify any incompatibilities. The order validation form contains a personalized message field provided for this purpose.
Click here to find the leaflet for this medication on the website of the National Agency for the Safety of Medicines and Health Products.
Pharmacovigilance : Declare an undesirable effect (s) linked to the use of a drug
Pharmacovigilance Report an adverse drug reaction(s)
ANSM - Updated on: 20/07/2017
CARLYTENE 30 mg, coated tablet
Moxisylyte Hydrochloride
Read this leaflet carefully before you start using this medicine. It contains important information for your treatment.
If you have any further questions, ask your doctor or pharmacist.
· Keep this leaflet, you may need to read it again.
· If you need more information and advice, ask your pharmacist.
· If symptoms worsen or persist, consult a physician.
· If you notice any side effects not listed in this leaflet, or if you experience any of the effects listed as serious, please tell your doctor or pharmacist.
In this notice :
1. WHAT IS CARLYTENE 30 mg, coated tablet AND WHAT IT IS USED FOR?
2. BEFORE YOU TAKE CARLYTENE 30 mg, coated tablet?
3. HOW TO TAKE CARLYTENE 30 mg coated tablet?
4. WHAT ARE POSSIBLE SIDE EFFECTS?
5. HOW TO STORE CARLYTENE 30 mg coated tablet?
6. ADDITIONAL INFORMATION
1. WHAT IS CARLYTENE 30 mg, coated tablet AND WHAT IT IS USED FOR?
PERIPHERAL VASODILATOR
(C: Cardiovascular System)
This medicine is indicated in:
· minor neurological disorders related to aging,
· Raynaud's syndrome (circulatory disorder of the extremities).
2. BEFORE YOU TAKE CARLYTENE 30 mg, coated tablet?
List of information needed before taking the medication
Not applicable.
Do not use CARLYTENE 30 mg coated tablets in the following cases:
· in the event of a history of allergy to moxisylyte or to any of the components of the tablet.
IN CASE OF DOUBT IT IS ESSENTIAL TO ASK FOR THE OPINION OF YOUR DOCTOR OR YOUR PHARMACIST
Precautions for use; special warnings
Take special care with CARLYTENE 30 mg, coated tablet:
Special warnings
There have been rare cases of liver damage, regressive on discontinuation of treatment, for doses greater than 90 mg per day.
It is therefore recommended not to exceed the 90 mg dose, ie 3 tablets per 24 hours.
Precautions for use
IN CASE OF DOUBT DO NOT HESITATE TO REQUEST THE NOTICE OF YOUR DOCTOR OR PHARMACIST.
Interaction with other medicines
Taking other medicines
If you are taking or have recently taken any other medicines, including medicines obtained without a prescription, talk to your doctor or pharmacist.
Interactions with food and beverages
Not applicable.
Interactions with Herbal Medicines or Alternative Therapies
Not applicable.
Use during pregnancy and lactation
Pregnancy and breast feeding
GENERALLY, DURING PREGNANCY OR BREASTFEEDING, ALWAYS ASK FOR THE OPINION OF YOUR DOCTOR OR PHARMACIST BEFORE USING A MEDICINE.
Not applicable.
Effects on ability to drive or use machines
Not applicable.
List of excipients with known effect
Not applicable.
3. HOW TO TAKE CARLYTENE 30 mg coated tablet?
Not applicable.
Dosage
1 tablet 30 mg, morning, noon and evening. Do not exceed 3 tablets per day.
THIS MEDICINE HAS BEEN PERSONALLY ISSUED OR PRESCRIBED IN A SPECIFIC SITUATION:
IT CAN NOT BE ADAPTED TO ANOTHER CASE.
DO NOT ADVISE IT TO ANOTHER PERSON.
Method and route of administration
Oral use.
Swallow the tablets without chewing them with a glass of water.
Frequency of Administration
Take the tablet preferably during meals.
Duration of treatment
Follow your doctor's prescription.
Symptoms and Instructions for Overdose
If you used more than CARLYTENE 30 mg, coated tablet you should:
Overdose may include hypotension, priapism (involuntary penile erection and painful erection), increased transaminases or hepatitis.
If you take more CARLYTENE 30 mg tablet coated than it should, contact your doctor immediately.
Instructions for omission of one or more doses
If you forget to take CARLYTENE 30 mg, coated tablet:
Take the next dose at the usual time; do not double the dose.
Not applicable.
4. WHAT ARE POSSIBLE SIDE EFFECTS?
Description of adverse reactions
· Minor digestive disorders (nausea, diarrhea).
· There have been rare cases of liver damage, regressive on discontinuation of treatment, for doses greater than 90 mg per day.
Declaration of side effects
If you experience any side effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and network of Regional Centers of Pharmacovigilance - Website: www.ansm.sante.fr .
By reporting adverse reactions, you are helping to provide more information about the safety of the drug.
5. HOW TO STORE CARLYTENE 30 mg coated tablet?
Keep out of the reach and sight of children.
Do not use CARLYTENE 30 mg coated tablets after the expiry date which is stated on the outer packaging.
No special storage conditions.
If necessary, warnings against visible signs of deterioration
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist what to do with unused medications. These measures will help protect the environment.
Full list of active substances and excipients
What contains CARLYTENE 30 mg coated tablet?
The active substance is:
Moxisylyte hydrochloride ............................................... .................................................. ........... 30.00 mg
For a coated tablet.
The other components are:
Talc, magnesium stearate, cellulose hydroxyalkyl ether, opacifying suspension * (SEPISPERSE / WHITE AP7001), polyethylene glycol 6000, lactose, amylaceous sucrose, corn starch, talc.
* Composition of the suspension Opacifying : dispersion of the titanium dioxide (E 171) in a mixture water, polyethylene glycol, methylhydroxypropylcellulose.
Pharmaceutical form and content
What is CARLYTENE 30 mg, coated tablet and contents of the pack?
This medication is in the form of a coated tablet. Box of 32 coated tablets.
40-44 WASHINGTON STREET
75008 PARIS
40-44 Washington Street
75008 PARIS
MEDA MANUFACTURING GMBH
NEURATHER RING 1
51063 COLOGNE
GERMANY
Names of the medicinal product in the Member States of the European Economic Area
Not applicable.
Date of approval of the notice
The last date on which this leaflet was approved is {date}.
AMM under exceptional circumstances
Not applicable.
Detailed information on this medicine is available on the Afssaps website (France).
Information for health professionals only
Not applicable.
Not applicable.
vasodilator
moxisylyte
. Presentations . Composition . Indications . Warning . Pregnancy and breastfeeding . Directions for use and dosage . Undesirable effects . Lexicon
CARLYTENE 30 mg: tablet (white); box of 32.
-
Laboratory Meda Pharma
| p cp | |
| Moxisylyte hydrochloride | 30 mg |
Usual dosage:
1 tablet, 3 times a day.
Progesteronum Boiron Homeopathic granules, doses or phials
CUPRUM Oxydatum NIGRUM 4C 9C 12C 7C 5 C 15C 30C HOMEOPATHIE Granules Boiron
